Literature DB >> 16678111

p53 stabilization and transactivation by a von Hippel-Lindau protein.

Jae-Seok Roe1, Hyungsoo Kim, Soon-Min Lee, Sung-Tae Kim, Eun-Jung Cho, Hong-Duk Youn.   

Abstract

von Hippel-Lindau (VHL) disease is a rare autosomal dominant cancer syndrome. Although hypoxia-inducible factor-alpha (HIFalpha) is a well-documented substrate of von Hippel-Lindau tumor suppressor protein (pVHL), it remains unclear whether the dysregulation of HIF is sufficient to account for de novo tumorigenesis in VHL-deleted cells. Here we found that pVHL directly associates with and stabilizes p53 by suppressing Mdm2-mediated ubiquitination and nuclear export of p53. Moreover, upon genotoxic stress, pVHL invoked an interaction between p53 and p300 and the acetylation of p53, which ultimately led to an increase in p53 transcriptional activity and p53-mediated cell cycle arrest and apoptosis. These results suggest that the tumor suppressor pVHL has an unexpected function to upregulate the tumor suppressor p53.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678111     DOI: 10.1016/j.molcel.2006.04.006

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  93 in total

Review 1.  Renal cancer: oxygen meets metabolism.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2012-03-03       Impact factor: 3.905

2.  Proteomic dissection of the von Hippel-Lindau (VHL) interactome.

Authors:  Yanlai Lai; Meihua Song; Kevin Hakala; Susan T Weintraub; Yuzuru Shiio
Journal:  J Proteome Res       Date:  2011-10-11       Impact factor: 4.466

3.  Trivalent arsenic inhibits the functions of chaperonin complex.

Authors:  Xuewen Pan; Stefanie Reissman; Nick R Douglas; Zhiwei Huang; Daniel S Yuan; Xiaoling Wang; J Michael McCaffery; Judith Frydman; Jef D Boeke
Journal:  Genetics       Date:  2010-07-26       Impact factor: 4.562

4.  pVHL-mediated transcriptional repression of c-Myc by recruitment of histone deacetylases.

Authors:  In-Young Hwang; Jae-Seok Roe; Ja-Hwan Seol; Hwa-Ryeon Kim; Eun-Jung Cho; Hong-Duk Youn
Journal:  Mol Cells       Date:  2012-02       Impact factor: 5.034

5.  Nur77 upregulates HIF-alpha by inhibiting pVHL-mediated degradation.

Authors:  Bu Yeon Kim; Hyungsoo Kim; Eun Jung Cho; Hong Duk Youn
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

6.  miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

Authors:  Seong-Yeon Park; Jung Hyun Lee; Minju Ha; Jin-Wu Nam; V Narry Kim
Journal:  Nat Struct Mol Biol       Date:  2008-12-14       Impact factor: 15.369

7.  Downregulation of integrins by von Hippel-Lindau (VHL) tumor suppressor protein is independent of VHL-directed hypoxia-inducible factor alpha degradation.

Authors:  Qingzhou Ji; Robert D Burk
Journal:  Biochem Cell Biol       Date:  2008-06       Impact factor: 3.626

8.  p53 regulates renal expression of HIF-1{alpha} and pVHL under physiological conditions and after ischemia-reperfusion injury.

Authors:  Timothy A Sutton; Jared Wilkinson; Henry E Mang; Nicole L Knipe; Zoya Plotkin; Maya Hosein; Katelyn Zak; Jeremy Wittenborn; Pierre C Dagher
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-24

9.  Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma.

Authors:  Christopher Ricketts; Maurice P Zeegers; Jan Lubinski; Eamonn R Maher
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240

10.  The Warburg effect is genetically determined in inherited pheochromocytomas.

Authors:  Judith Favier; Jean-Jacques Brière; Nelly Burnichon; Julie Rivière; Laure Vescovo; Paule Benit; Isabelle Giscos-Douriez; Aurélien De Reyniès; Jérôme Bertherat; Cécile Badoual; Frédérique Tissier; Laurence Amar; Rosella Libé; Pierre-François Plouin; Xavier Jeunemaitre; Pierre Rustin; Anne-Paule Gimenez-Roqueplo
Journal:  PLoS One       Date:  2009-09-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.